Angiodynamics (ANGO) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $41.6 million.
- Angiodynamics' Cash & Current Investments fell 2301.95% to $41.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was $41.6 million, marking a year-over-year decrease of 2301.95%. This contributed to the annual value of $55.9 million for FY2025, which is 2651.07% down from last year.
- According to the latest figures from Q4 2025, Angiodynamics' Cash & Current Investments is $41.6 million, which was down 2301.95% from $38.8 million recorded in Q3 2025.
- In the past 5 years, Angiodynamics' Cash & Current Investments registered a high of $78.5 million during Q1 2024, and its lowest value of $23.9 million during Q1 2022.
- In the last 5 years, Angiodynamics' Cash & Current Investments had a median value of $44.7 million in 2023 and averaged $45.9 million.
- As far as peak fluctuations go, Angiodynamics' Cash & Current Investments crashed by 5614.02% in 2022, and later soared by 16053.93% in 2024.
- Over the past 5 years, Angiodynamics' Cash & Current Investments (Quarter) stood at $34.3 million in 2021, then dropped by 12.93% to $29.9 million in 2022, then skyrocketed by 103.96% to $60.9 million in 2023, then dropped by 11.18% to $54.1 million in 2024, then dropped by 23.02% to $41.6 million in 2025.
- Its last three reported values are $41.6 million in Q4 2025, $38.8 million for Q3 2025, and $55.9 million during Q2 2025.